The Board of Pharmacy announced it is seeking pre-Notice comments on its draft statewide protocol for pharmacists to test and treat patients for COVID-19. Comments may be submitted through October 22 to Sue Mears at sue.mears@iowa.gov.
Also in Iowa, the Board of Pharmacy alerted licensees and registrants about recent activities by individuals posing as employees of the Board, DEA and FDA.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.